News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
111 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Teva Surges After Warren Buffett’s Berkshire Reports $358M Stake
Teva got a nice shot in the arm after reports that billionaire investor Warren Buffett took a stake in the company.
February 15, 2018
·
2 min read
·
Alex Keown
Pharm Country
Superstar Investors Jump in on Celgene Spinout Celularity’s $250M Funding Round
Celularity is a biotech founded by stem cell pioneer Robert Hariri, MD, PhD.
February 15, 2018
·
3 min read
·
Mark Terry
Bio NC
2 Biotechs With the Potential of Doubling Investors’ Cash
Analyst price targets for these two biotechs suggest they could double your money. Here’s what you need to know.
February 15, 2018
·
1 min read
Business
Beleaguered Axovant Begins Cutting Jobs While Exiting CEO Gets $2.6M+ Severance Package
The news was revealed in a filing with the SEC.
February 15, 2018
·
2 min read
·
Alex Keown
Drug Development
Vertex Nixes Three Planned Phase III CF Trials in France
Vertex has declined to comment, but BioCentury received a copy of the letter the company sent to laboratories explaining.
February 15, 2018
·
3 min read
·
Mark Terry
Deals
4 Small Biotech M&A Targets for Gilead
Investors and analysts had been encouraging Gilead to acquire something for a long time, so they were mostly happy when it bought Kite Pharma in September.
February 15, 2018
·
3 min read
·
Mark Terry
Drug Development
Biogen Plunges After Making Changes to Alzheimer’s Drug Trial
Shares dropped by 9.1 percent, the biggest intraday decline since June 2016.
February 15, 2018
·
3 min read
·
Mark Terry
Business
Acelity to Slash 68 Jobs
The employees will be let go by May 8, 2018.
February 15, 2018
·
1 min read
Drug Development
Merck KGaA, Pfizer’s Lung Cancer Drug Flunks Late-Stage Trial
Detailed results from the JAVELIN Lung 200 trial will be submitted for presentation at an upcoming medical congress.
February 15, 2018
·
3 min read
·
Mark Terry
Business
ICON Reports Fourth Quarter and Full Year 2017 Results
In the fourth quarter net revenue grew 4.6% year on year to $455 million from $435 million in the same quarter last year.
February 15, 2018
·
10 min read
1 of 12
Next
